ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,629.00
0.55%
S&P ASX All Technology
3,016.30
1.48%
Brent Oil
82.765
0.00%
US Dollar vs AUD
1.514
-0.05%
Bitcoin
63,019.16
0.21%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. NeuroOne Medical Technologies Corporation (NMTC)

  7. NeuroOne Medical Technologies Corporation (NMTC) News

NMTC NeuroOne Medical Technologies Corporation

1.1899
-0.0201 (-1.66%)
04 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
NeuroOne Medical Technologies Corporation NMTC NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
-0.0201 -1.66% 1.1899 09:19:56
Open Price Low Price High Price Close Price Previous Close
1.23 1.15 1.231 1.17 1.21
more quote information »

Recent News

Date Time Source Heading
10/4/202423:00GLOBENeuroOne® CEO Dave Rosa Featured on Bloomberg Technology
09/4/202423:05GLOBENeuroOne® Announces First Implant of OneRF™ Ablation..
05/4/202400:00GLOBENeuroOne® CEO Dave Rosa Featured on Fox Business Network’s..
27/3/202400:00GLOBENeuroOne® Initiates Limited Commercial Launch of OneRF™..
09/3/202404:00GLOBENeuroOne® to Participate in the 36th Annual Roth Conference
05/3/202406:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202406:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202405:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/2/202409:10GLOBENeuroOne Reports Inducement Grant Under Nasdaq Listing Rule..
22/2/202403:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202402:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202402:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202402:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202408:15EDGAR2Form 8-K - Current report
14/2/202408:00GLOBENeuroOne® Reports First Quarter Fiscal Year 2024 Financial..
09/2/202407:30GLOBENeuroOne® to Report First Quarter Fiscal Year 2024 Financial..
02/2/202405:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202405:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202405:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202408:09EDGAR2Form S-8 - Securities to be offered to employees in employee..
30/1/202401:02EDGAR2Form ARS - Annual Report to Security Holders
30/1/202401:00EDGAR2Form DEF 14A - Other definitive proxy statements
06/1/202408:16EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
04/1/202405:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202405:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202405:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/12/202310:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202308:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202308:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202301:35EDGAR2Form 144 - Report of proposed sale of securities
16/12/202308:45EDGAR2Form S-8 - Securities to be offered to employees in employee..
16/12/202308:39EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
15/12/202308:30EDGAR2Form 8-K - Current report
15/12/202308:15GLOBENeuroOne® Reports Fiscal Fourth Quarter and Full Fiscal Year..
12/12/202300:15EDGAR2Form 8-K - Current report
12/12/202300:00GLOBENeuroOne® Receives FDA 510(k) Clearance to Market its OneRF™..
08/12/202308:30GLOBENeuroOne® to Report Fourth Quarter and Fiscal Year 2023..
05/12/202308:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202308:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202308:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/12/202308:55EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
17/11/202300:00EDGAR2Form 8-K - Current report
17/11/202300:00GLOBENeuroOne® Announces Patent Allowance for Drug Delivery..
15/11/202309:15GLOBENeuroOne® Appoints Medtech Executive Christopher R. Volker..
14/11/202310:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202309:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202309:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202309:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202300:15EDGAR2Form 8-K - Current report
08/11/202300:00GLOBENeuroOne® Provides Progress Update on FDA 510(k) Submission..

Your Recent History

NASDAQ
NMTC
NeuroOne Medical Technol...
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved